je.st
news
Tag: regeneron
Regeneron Pharmaceuticals major shareholder Sanofi Acquires 147,209 Shares
2015-09-27 09:48:03| Apparel - Topix.net
Regeneron Pharmaceuticals major shareholder Sanofi bought 147,209 shares of Regeneron Pharmaceuticals stock in a transaction on Wednesday, September 23rd. The shares were bought at an average cost of $534.67 per share, with a total value of $78,708,236.03.
Tags: major
shares
shareholder
pharmaceuticals
Canaccord Genuity Reaffirms Buy Rating for Regeneron Pharmaceuticals
2015-08-30 19:41:11| Biotech - Topix.net
's stock had its "buy" rating restated by research analysts at Canaccord Genuity in a research report issued on Wednesday, Market Beat Ratings reports. They presently have a $700.00 price target on the biopharmaceutical company's stock, up from their previous price target of $600.00.
Tags: buy
rating
pharmaceuticals
reaffirms
Weekly Analysts' Ratings Changes for Regeneron Pharmaceuticals
2015-08-27 14:16:29| Biotech - Topix.net
They now have a $565.00 price target on the stock. 8/20/2015 - Regeneron Pharmaceuticals was upgraded by analysts at Vetr from a "buy" rating to a "strong-buy" rating.
Tags: ratings
weekly
analysts
pharmaceuticals
Regeneron Pharmaceuticals: 2 More Factors That Could Boost Stock Price
2015-08-06 12:47:38| Biotech - Topix.net
The company is moving closer to a stage where it might consider returning some cash to shareholders, which will boost returns. Regeneron Pharmaceuticals shares rose to an all-time high level on Tuesday as the company reported solid results for the second quarter and raised its revenue guidance for the full year.
Tags: price
stock
factors
boost
Regeneron Pharmaceuticals Given "Outperform" Rating at RBC Capital
2015-06-06 21:12:59| Biotech - Topix.net
REGN has been the subject of a number of other recent research reports. Analysts at Piper Jaffray reiterated a "neutral" rating and set a $484.00 price target on shares of Regeneron Pharmaceuticals in a research note on Thursday, May 21st.
Tags: rating
capital
pharmaceuticals
rbc